Cargando…

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

SIMPLE SUMMARY: Uterine serous cancer (USC) is an aggressive form of endometrial cancer. USC constitutes less than 10% of endometrial cancer cases but is responsible for up to 40% of endometrial cancer deaths. Response to standard platinum and taxane therapy is modest, particularly in the recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toboni, Michael D., Lomonosova, Elena, Bruce, Shaina F., Tankou, Jo’an I., Mullen, Mary M., Schab, Angela, Oplt, Alyssa, Noia, Hollie, Wilke, Danny, Kuroki, Lindsay M., Hagemann, Andrea R., McCourt, Carolyn K., Thaker, Premal H., Powell, Matthew A., Khabele, Dineo, Mutch, David G., Fuh, Katherine C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656641/ https://www.ncbi.nlm.nih.gov/pubmed/34884986 http://dx.doi.org/10.3390/cancers13235877

Ejemplares similares

Persistent inequities in access to and continuity of gynecologic oncology care during the COVID-19 pandemic (052)
por: Bruce, Shaina, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care
por: Bruce, Shaina F., et al.
Publicado: (2022)

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery
por: Zamorano, Abigail S., et al.
Publicado: (2022)

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
por: Kotnik, Emilee N., et al.
Publicado: (2023)

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer
por: Johns, E.A., et al.
Publicado: (2021)

AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer
por: Divine, Laura M., et al.
Publicado: (2016)

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
por: Compadre, Amanda J., et al.
Publicado: (2023)

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention
por: Huepenbecker, Sarah P., et al.
Publicado: (2022)

Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?
por: Cripe, James C., et al.
Publicado: (2019)

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?
por: Liang, Brooke, et al.
Publicado: (2019)

Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy
por: Leng, Xiandong, et al.
Publicado: (2022)

Obese endometrial cancer survivors’ perceptions of weight loss strategies and characteristics that may influence participation in behavioral interventions
por: Wilson, Elise M., et al.
Publicado: (2021)

The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020)

Patients with endometrial cancer continue to lack understanding of their risks for cancer
por: Sekhon, Subhjit, et al.
Publicado: (2019)

p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts
por: Mills, Kathryn A., et al.
Publicado: (2019)

The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014)

Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer
por: Kuroki, Lindsay M., et al.
Publicado: (2015)

Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors
por: Choi, Hyeongjwa, et al.
Publicado: (2017)

MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome
por: Kumar, Aswathi, et al.
Publicado: (2023)

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
por: Petersen, Shariska, et al.
Publicado: (2020)

Optical Resolution Photoacoustic Microscopy of Ovary and Fallopian Tube
por: Rao, Bin, et al.
Publicado: (2019)

A Case of Extrauterine Endometrial Stromal Sarcoma in the Colon Diagnosed Three Decades after Hysterectomy for Benign Disease
por: Ayuso, Andres, et al.
Publicado: (2013)

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
por: Gupta, Vijayalaxmi, et al.
Publicado: (2018)

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
por: Mills, Kathryn A., et al.
Publicado: (2019)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
por: Jewell, Andrea, et al.
Publicado: (2018)

Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
por: Wilson, Andrew J, et al.
Publicado: (2012)

Adrenal Gland Metastasis Is an Unusual Manifestation of Endometrial Cancer
por: Zaidi, Syeda Sadia, et al.
Publicado: (2013)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Human papillomavirus vaccination completion rates among gynecological providers: an institutional retrospective review
por: Elsamadicy, Emad A., et al.
Publicado: (2019)

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021)

Incidental placenta increta at the time of prophylactic hysterectomy for Lynch syndrome: Insights into individualized decision-making and surgical timing
por: Nielsen, Tara A., et al.
Publicado: (2015)

Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP-Ribose) polymerase inhibitors against BRCA1/2 wild-type ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Obesity counseling in obstetrics and gynecology: provider perceptions and barriers
por: Huepenbecker, Sarah P., et al.
Publicado: (2018)

The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
por: Fritz, Helena K., et al.
Publicado: (2015)

Immune Evasion Mechanism and AXL
por: Son, Hye-Youn, et al.
Publicado: (2021)

Patent Spring Washer Axles
Publicado: (1878)

Preferential Effect of Akt2-Dependent Signaling on the Cellular Viability of Ovarian Cancer Cells in Response to EGF
por: Khabele, Dineo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mr13lh6oi0dl42nlf77nvb4fgs